UnitedHealth Faces Pressure from Medicare Rates Despite Raymond James Upgrade

UnitedHealth Group (UNH) shares experienced volatility following a proposed 0.09% increase in Medicare Advantage rates. Investors expressed concern that this marginal hike might not sufficiently cover rising medical costs, potentially squeezing profit margins. Despite these regulatory headwinds, Raymond James upgraded the stock to 'Outperform' and set a price target of $330. Analysts highlighted the company's robust financial performance, noting revenue of $447.6 billion over the trailing 12 months. Furthermore, internal efficiencies within the Optum Health segment are expected to provide a buffer against Medicare-related pricing pressures. This mixed outlook reflects a balance between immediate regulatory challenges and long-term operational strength in the healthcare sector.